Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
- 13 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (5), 781-791
- https://doi.org/10.1038/s41591-020-0818-3
Abstract
Although immunotherapy has revolutionized cancer treatment, only a subset of patients demonstrate durable clinical benefit. Definitive predictive biomarkers and targets to overcome resistance remain unidentified, underscoring the urgency to develop reliable immunocompetent models for mechanistic assessment. Here we characterize a panel of syngeneic mouse models, representing a variety of molecular and phenotypic subtypes of human melanomas and exhibiting their diverse range of responses to immune checkpoint blockade (ICB). Comparative analysis of genomic, transcriptomic and tumor-infiltrating immune cell profiles demonstrated alignment with clinical observations and validated the correlation of T cell dysfunction and exclusion programs with resistance. Notably, genome-wide expression analysis uncovered a melanocytic plasticity signature predictive of patient outcome in response to ICB, suggesting that the multipotency and differentiation status of melanoma can determine ICB benefit. Our comparative preclinical platform recapitulates melanoma clinical behavior and can be employed to identify mechanisms and treatment strategies to improve patient care.Keywords
This publication has 70 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- A Melanoma Molecular Disease ModelPLOS ONE, 2011
- Sun and Solarium Exposure and Melanoma Risk: Effects of Age, Pigmentary Characteristics, and NeviCancer Epidemiology, Biomarkers & Prevention, 2010
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Ultraviolet B but not Ultraviolet A Radiation Initiates MelanomaCancer Research, 2004
- Neonatal sunburn and melanoma in miceNature, 2001